LIU Xiao-qing, LI Feng. Efficacy and Safety of Maintenance Bevacizumab Combined with Pemetrexed after First-Line Induction Chemotherapy in Advanced Nonsquamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 33-36. DOI: 10.3969/j.issn.1671-5144.2014.01.004
|
Citation:
|
LIU Xiao-qing, LI Feng. Efficacy and Safety of Maintenance Bevacizumab Combined with Pemetrexed after First-Line Induction Chemotherapy in Advanced Nonsquamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 33-36. DOI: 10.3969/j.issn.1671-5144.2014.01.004
|
LIU Xiao-qing, LI Feng. Efficacy and Safety of Maintenance Bevacizumab Combined with Pemetrexed after First-Line Induction Chemotherapy in Advanced Nonsquamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 33-36. DOI: 10.3969/j.issn.1671-5144.2014.01.004
|
Citation:
|
LIU Xiao-qing, LI Feng. Efficacy and Safety of Maintenance Bevacizumab Combined with Pemetrexed after First-Line Induction Chemotherapy in Advanced Nonsquamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 33-36. DOI: 10.3969/j.issn.1671-5144.2014.01.004
|
DownLoad: